Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
- Annayya R. Aroor
- , Nitin A. Das
- , Andrea J. Carpenter
- , Javad Habibi
- , Guanghong Jia
- , Francisco I. Ramirez-Perez
- , Luis Martinez-Lemus
- , Camila M. Manrique-Acevedo
- , Melvin R. Hayden
- , Cornel Duta
- , Ravi Nistala
- , Eric Mayoux
- , Jaume Padilla
- , Bysani Chandrasekar
- , Vincent G. DeMarco
Research output: Contribution to journal › Article › peer-review
158
Link opens in a new tab
Scopus
citations